TRANSCEND BIODYNAMICS
Transcend is a research-focused biotechnology company creating and clinically validating an evolving IP portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization. Transcend is focused on developing second generation psychedelic compounds, peptides, pro-drugs, and nutraceuticals to address unmet needs within mental health, wellness, and anti-aging industries.
More informations about "Transcend Biodynamics"
BetterLife Closes Acquisition of Second Generation Psychedelic …
VANCOUVER, Dec. 20, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further …See details»
BetterLife Closes Acquisition of Second Generation - GlobeNewswire
Dec 21, 2020 About Transcend Biodynamics LLC. Transcend is a research focused biotechnology company creating and clinically validating an evolving IP portfolio of novel …See details»
BetterLife Closes Acquisition of Second Generation ... - BioSpace
Dec 21, 2020 BetterLife Pharma Inc. is pleased to announce that further to its press release of December 8, 2020, the Company has completed its acquisition to acquire 100% of the assets …See details»
Betterlife Pharma acquires Transcend Biodynamics - 2020-12-08 ...
Transcend Biodynamics Transcend Biodynamics manufacturing patent “Process of synthesizing 2-Bromo-LSD.” Acquiring Organization: Betterlife Pharma Betterlife is a bio-pharma …See details»
BetterLife adds Next-Gen Psychedelic Therapy to its
Dec 8, 2020 About Transcend Biodynamics LLC. Transcend is a research focused biotechnology company creating and clinically validating an evolving IP portfolio of novel …See details»
Transcend Biodynamics - PitchBook
Transcend Biodynamics General Information Description. Developer of therapeutic drugs and related biotech compounds, focused on addressing unmet mental health needs by creating …See details»
Transcend Biodynamics - Products, Competitors, Financials, …
Transcend Biodynamics is a biotech company focused on addressing unmet mental health needs by developing next generation psychedelic therapeutics, which include the Lysergic Acid …See details»
BetterLife Pharma buys Transcend, adds LSD derivatives to its …
Dec 22, 2020 According to reliable sources, Canadian biotechnology company BetterLife Pharma Inc. has completed the acquisition of Transcend Biodynamics LLC and has obtained …See details»
BetterLife’s Recent Acquisition: Taking LSD from ... - BioSpace
VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on …See details»
Betterlife Pharma - Funding, Financials, Valuation & Investors
Betterlife Pharma has acquired Transcend Biodynamics on Dec 8, 2020. They acquired Transcend Biodynamics for $10M. Which types of acquisition does this organization make …See details»
BetterLife Closes Acquisition of Second Generation Psychedelic …
Dec 21, 2020 About Transcend Biodynamics LLC. Transcend is a research focused biotechnology company creating and clinically validating an evolving IP portfolio of novel …See details»
BetterLife Closes Acquisition of Second Generation Psychedelic …
Dec 21, 2020 BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further to its press release of December 8, …See details»
BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of …
Dec 8, 2020 Transcend is a research driven biotechnology company committed to addressing unmet mental health needs through the development of patented next generation psychedelic …See details»
Transcend Biodynamics LLC - Drug pipelines, Patents, Clinical trials ...
Explore Transcend Biodynamics LLC with its drug pipeline, therapeutic area, technology platform, . Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last update 02 …See details»
BetterLife Pharma completes C$10M acquisition of LSD derivative …
Dec 21, 2020 READ: BetterLife Pharma adds LSD derivative to its pipeline with C$10M Transcend Biodynamics acquisition. BOL-148 is a non-toxic second-generation LSD-derived …See details»
BetterLife’s Recent Acquisition: Taking LSD from - GlobeNewswire
Dec 15, 2020 About Transcend Biodynamics. Transcend is a research focused biotechnology company creating and clinically validating an evolving IP portfolio of novel molecules and drug …See details»
BetterLife Pharma to Acquire Transcend Biodynamics
Dec 8, 2020 Home BetterLife Pharma to Acquire Transcend Biodynamics. December 8, 2020 BetterLife Pharma to Acquire Transcend Biodynamics Prev post Next post. 1275 West 6th …See details»
Press Release: BetterLife Pharma completes C$10M acquisition of …
Transcend owns BOL-148, a non-toxic second-generation LSD-derived molecule that mimics the therapeutic potential of LSD, without the psychedelic effects or hallucinations BetterLife …See details»
BetterLife Closes Acquisition of Second Generation Psychedelic …
Dec 23, 2020 VANCOUVER — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) is pleased to announce that further to its press release …See details»